ANZ news
Singular Health scores 510(k) for 3D DICOM viewer software
ASX-listed medical technology firm Singular Health Group has received a 510(k) clearance from the US Food and Drug Administration for 3Dicom MD.
The software-as-a-medical device allows medical practitioners to collaboratively visualise standard CT/MRI and PET scans in 2D and 3D in real time. It also has built-in voice and text chat and...
The Australian government has awarded grants to research projects working on wearable technology to improve health monitoring for Australians.
A project at Curtin University, which has been provided with A$1.5 million ($950,000) funding, will develop and test wearable sensors to monitor the movement of children with cerebral palsy who are unable to walk.
Another project at the University of New...
Researchers from Neuroscience Research Australia and the University of New South Wales have come up with an algorithm that provides an accurate measurement of walking steadiness and speed.
WHAT IT'S ABOUT
Dubbed Watch Walk, the digital gait biomarker algorithm measures gait with a smart watch’s in-built accelerometer. It measures aspects of an individual's manner of walking, such as posture,...
A research team led by engineers and neurologists at RMIT University has come up with a mobile app that uses a person's voice to screen for Parkinson's disease and severe COVID-19.
HOW IT WORKS
The app uses AI to analyse the changes in a person's voice in just 10 seconds. The research gathered voice recordings of people with Parkinson's and a control group saying three sounds – A, O, and M,...
Klaus Bartosch has formally resigned as CEO and managing director of Australian digital health group 1st Group.
1st Group operates the health services marketplace MyHealth1st.com.au and telehealth platform Visionflex, which it acquired early this year.
In a statement, Bartosch, who helped co-found the company over a decade ago, said that while it has been a difficult decision, his resignation is...
Pfizer completes ResApp purchase for over $115 million
Biopharmaceutical giant Pfizer has finalised its acquisition of ASX-listed digital health startup ResApp for A$179 million ($116 million), according to the University of Queensland.
Brisbane-based ResApp has developed a mobile app that analyses cough sounds and diagnoses respiratory diseases, including asthma, pneumonia, bronchiolitis, croup...
A new robotic arm at the Kolling Institute, a joint venture between the Northern Sydney Local Health District and the University of Sydney, is seen to improve hip and knee replacements in Australia.
WHAT IT DOES
Called KOBRA (Kolling Orthopaedic Biomechanics Robotic Arm), the orthopaedic biomechanics robot is one of the only two robots in the country that is based on simVitro – a hardware...
HealthMatch, an Australian startup offering a platform for matching patients to clinical trials, has recently closed a A$10 million ($6.8 million) Series C funding round led by Folklore Ventures. The round was also joined by Square Peg Capital and other investors.
Launched in 2017, the company is now being used by over one million patients worldwide and has made over 3.6 million matches to...
Medtech startup Nutromics has received a $14 million investment from strategic investors, including Dexcom Ventures, VU Venture Partners, and Artesian Investments.
Founded in 2017, the company is developing a continuous diagnostic monitoring platform called lab-in-a-patch that uses DNA sensor technology to track multiple targets in the human body, including disease biomarkers and hard-to-dose...
An international study led by Monash University has done what could be the world's first demonstration of an AI model that can predict the optimal anti-seizure medication for newly diagnosed epilepsy patients.
WHAT IT'S ABOUT
The research team has trained a deep-learning prediction model using clinical information from around 1,800 patients in five health care centres in Australia, Malaysia,...
